Stay updated on Nivolumab Ipilimumab in CKS Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab in CKS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check20 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1. No changes to the study details, eligibility criteria, or other user-visible content were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe additions and deletions are UI-level changes that do not affect core study data such as eligibility, outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe only visible change is the revision update from v3.3.3 to v3.3.4, with no edits to the study content or page behavior. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page shows an update to the site footer/release notes: Revision: v3.3.3 was added, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision on the page updated from v3.2.0 to v3.3.2. The change appears to be a site version update and does not affect the study details.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab in CKS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.